Description:
A drug used alone or with other drugs to treat adults with certain types of endometrial cancer or other solid tumors that have come back or are advanced. These include cancers that have certain mutations (changes) in genes involved in DNA repair. It is also being studied in the treatment of other types of cancer. Dostarlimab binds to a protein called PD-1, which is found on T cells (a type of immune cell). Dostarlimab may block PD-1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called Jemperli.
